Sarepta Therapeutics Inc (SRPT) — Cash Flow-to-Debt Ratio
Sarepta Therapeutics Inc (SRPT) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of $-5.61 Million could theoretically repay 0% of its total liabilities ($1.66 Billion) in one year. See SRPT financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sarepta Therapeutics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Sarepta Therapeutics Inc across 31 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sarepta Therapeutics Inc.
Annual Cash Flow-to-Debt Ratio for Sarepta Therapeutics Inc (1995–2025)
Year-by-year debt coverage analysis for Sarepta Therapeutics Inc. Check SRPT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-205.48 Million | $2.21 Billion | ▼ -10.1% |
| 2024 | -0.08x | $-205.79 Million | $2.44 Billion | ▲ +59.4% |
| 2023 | -0.21x | $-500.99 Million | $2.41 Billion | ▼ -75.6% |
| 2022 | -0.12x | $-325.35 Million | $2.74 Billion | ▲ +40.6% |
| 2021 | -0.20x | $-443.17 Million | $2.22 Billion | ▼ -512.9% |
| 2020 | 0.05x | $107.47 Million | $2.22 Billion | ▲ +110.6% |
| 2019 | -0.45x | $-456.46 Million | $1.00 Billion | ▲ +28.7% |
| 2018 | -0.64x | $-388.66 Million | $609.80 Million | ▼ -42.5% |
| 2017 | -0.45x | $-232.00 Million | $518.75 Million | ▲ +84.1% |
| 2016 | -2.81x | $-245.82 Million | $87.41 Million | ▼ -57.0% |
| 2015 | -1.79x | $-149.47 Million | $83.44 Million | ▲ +34.0% |
| 2014 | -2.71x | $-128.54 Million | $47.38 Million | ▼ -86.1% |
| 2013 | -1.46x | $-64.69 Million | $44.38 Million | ▼ -299.2% |
| 2012 | -0.37x | $-29.69 Million | $81.31 Million | ▲ +64.0% |
| 2011 | -1.01x | $-23.68 Million | $23.35 Million | ▼ -225.3% |
| 2010 | -0.31x | $-15.21 Million | $48.79 Million | ▼ -28.9% |
| 2009 | -0.24x | $-8.80 Million | $36.40 Million | ▲ +80.8% |
| 2008 | -1.26x | $-12.34 Million | $9.80 Million | ▲ +37.5% |
| 2007 | -2.01x | $-24.68 Million | $12.26 Million | ▲ +69.2% |
| 2006 | -6.54x | $-20.61 Million | $3.15 Million | ▼ -22.6% |
| 2005 | -5.34x | $-14.67 Million | $2.75 Million | ▲ +49.5% |
| 2004 | -10.57x | $-23.78 Million | $2.25 Million | ▼ -126.8% |
| 2003 | -4.66x | $-17.48 Million | $3.75 Million | ▼ -17.8% |
| 2002 | -3.96x | $-20.26 Million | $5.12 Million | ▼ -1.2% |
| 2001 | -3.91x | $-12.82 Million | $3.28 Million | ▲ +26.2% |
| 2000 | -5.30x | $-9.13 Million | $1.72 Million | ▲ +30.3% |
| 1999 | -7.60x | $-7.60 Million | $1.00 Million | ▼ -36.1% |
| 1998 | -5.58x | $-6.70 Million | $1.20 Million | ▲ +6.9% |
| 1997 | -6.00x | $-3.00 Million | $500.00K | ▼ -1175.0% |
| 1996 | -0.47x | $-1.60 Million | $3.40 Million | ▲ +92.1% |
| 1995 | -5.93x | $-1.78 Million | $300.00K | — |